Vista Pharmaceuticals Intrinsic Value
VISTAPH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹21.07 | ₹18.96 - ₹23.18 | +149.9% | Book Value/Share: ₹37.50, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹15.00 | ₹13.50 - ₹16.50 | +77.9% | Revenue/Share: ₹7.50, P/S: 2.0x |
Want to compare with current market value? Check VISTAPH share price latest .
Valuation Comparison Chart
VISTAPH Intrinsic Value Analysis
What is the intrinsic value of VISTAPH?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Vista Pharmaceuticals (VISTAPH) is ₹21.07 (median value). With the current market price of ₹8.43, this represents a +149.9% variance from our estimated fair value.
The valuation range spans from ₹15.00 to ₹21.07, indicating ₹15.00 - ₹21.07.
Is VISTAPH undervalued or overvalued?
Based on our multi-method analysis, Vista Pharmaceuticals (VISTAPH) appears to be trading below calculated value by approximately 149.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 8.33 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.33 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -15.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -99.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.15x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Vista Pharmaceuticals
Additional stock information and data for VISTAPH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-5 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-2 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |